- Home
- SPCE vs FENC Comparison
SPCE vs FENC Comparison
Compare SPCE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | 694 | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.2M | 230.8M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SPCE | FENC |
|---|---|---|
| Price | $3.25 | $9.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $3.06 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 8.3M | 270.7K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.84 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $1,544,000.00 | ★ $44,642,000.00 |
| Revenue This Year | $2,270.73 | $65.12 |
| Revenue Next Year | $880.03 | $41.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $5.65 |
| 52 Week High | $5.23 | $10.27 |
Technical Indicators
Market Signals| Indicator | SPCE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 76.29 |
| Support Level | $2.96 | $7.45 |
| Resistance Level | $3.39 | $9.92 |
| Average True Range (ATR) | 0.30 | 0.65 |
| MACD | 0.03 | 0.30 |
| Stochastic Oscillator | 81.89 | 85.82 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.